| Issue Type | Login |
|---|---|
| Country | United Kingdom |
| Industry | Login |
| Region | Login |
| Maturity Date | 2031-11-13 |
| Par Value | 50000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 350.00 |
| Coupon | 5.75 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 350 |
| Min. Piece | Login |
| Min. Increment | Login |
This Astrazeneca plc corporate note has a 5.75% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 350.00 million GBP and matures on November 13, 2031 with a last coupon date of FEB 28, 2020. |
AstraZeneca plc, founded in 1999 and headquartered in Cambridge, UK, is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of prescription medicines. The company focuses on oncology, cardiovascular, renal, and respiratory therapies, alongside a notable pipeline in rare diseases and vaccine development.